Bromide

Bromide

SCHEMBL5088372

Br.CCCCCCC(CC)C(P)(CC)CC

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FDPS P14324 4/20 0.40
LMNA P02545 1/20 0.35
DNM1 Q05193 2/20 0.34
OPRM1 P35372 1/20 0.33
TSHR P16473 1/20 0.33
THRB P10828 1/20 0.33
GPR84 Q9NQS5 3/20 0.32
SPHK1 Q9NYA1 1/20 0.32
FFAR1 O14842 1/20 0.32
MAPT P10636 1/20 0.31
LCK P06239 1/20 0.31
PPARD Q03181 1/20 0.31
ZDHHC20 Q5W0Z9 1/20 0.31
ZDHHC2 Q9UIJ5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL921148 1.00 FDPS (0.40) FDPSLMNADNM1OPRM1TSHR
Bromide SCHEMBL5086835 1.00 FDPS (0.40) FDPSLMNADNM1OPRM1TSHR
Bromide SCHEMBL5091622 1.00 FDPS (0.40) FDPSLMNADNM1OPRM1TSHR
Bromide SCHEMBL5086699 1.00 FDPS (0.40) FDPSLMNADNM1OPRM1TSHR
Bromide SCHEMBL5088583 1.00 FDPS (0.40) FDPSLMNADNM1OPRM1TSHR
Bromide SCHEMBL10486476 1.00 FDPS (0.40) FDPSLMNADNM1OPRM1TSHR
Bromide SCHEMBL5087655 1.00 FDPS (0.40) FDPSLMNADNM1OPRM1TSHR
Bromide SCHEMBL1011394 1.00 FDPS (0.40) FDPSLMNADNM1OPRM1TSHR
Bromide SCHEMBL5085114 0.98 FDPS (0.37) FDPSLMNADNM1OPRM1
SCHEMBL22367822 0.98 FDPS (0.41) FDPSLMNADNM1OPRM1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026087965-A1 COMPOSITION COMPRISING EPOXY RESIN WITH CONSTRAINED AROMATIC RINGS AND PHOTOBASE 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-04-30 WO disclosed
WO-2025200154-A1 TWO-PART EPOXY COMPOSITION COMPRISING THIOL CURATIVE, AND CATALYST 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-10-02 WO disclosed
CN-117482706-A Solid acid catalyzed ionic liquid CO 2 Method for desorbing rich liquid 中国石油大学(北京) 2024-02-02 CN disclosed
EP-3653663-B1 MOLDED ARTICLE AND ITS PRODUCTION METHOD TORAY INDUSTRIES (JP) 2022-12-28 EP disclosed
WO-2022210246-A1 EPOXY RESIN COMPOSITION, CURED EPOXY RESIN PRODUCT, AND COATED FIBER-REINFORCED RESIN MOLDED ARTICLE OBTAINED USING SAME 東レ株式会社 2022-10-06 WO disclosed
US-20220127293-A1 LIQUID METAL COMPLEX HAVING OXYGEN-ABSORBING ABILITY SHARP KABUSHIKI KAISHA (JP) 2022-04-28 US disclosed
CN-108602009-B Liquid having oxygen absorption capacity, method for producing the same, and composite solution containing the same 夏普株式会社 2021-07-27 CN disclosed
EP-3409343-B1 LIQUID HAVING OXYGEN ABSORBING ABILITY, METHOD FOR PRODUCING SAME, AND COMPLEX SOLUTION CONTAINING SAME SHARP KK (JP) 2021-04-28 EP disclosed
US-10814269-B2 Liquid having oxygen absorbing ability, method for producing same, and complex solution containing same SHARP KABUSHIKI KAISHA (JP) 2020-10-27 US disclosed
WO-2020184336-A1 LIQUID METAL COMPLEX HAVING OXYGEN-ABSORBING ABILITY シャープ株式会社 2020-09-17 WO disclosed
US-20200148847-A1 MOLDED ARTICLE AND PRODUCTION METHOD THEREFOR TORAY INDUSTRIES, INC. (JP) 2020-05-14 US disclosed
US-20190291046-A1 OXYGEN SEPARATION MEMBRANE SHARP KABUSHIKI KAISHA (JP) 2019-09-26 US disclosed
EP-3485965-A1 OXYGEN SEPARATION MEMBRANE Sharp Kabushiki Kaisha (JP) 2019-05-22 EP disclosed
US-20190001260-A1 LIQUID HAVING OXYGEN ABSORBING ABILITY, METHOD FOR PRODUCING SAME, AND COMPLEX SOLUTION CONTAINING SAME NATIONAL UNIVERSITY CORP. KOBE UNIVERSITY (JP) 2019-01-03 US disclosed
EP-3409343-A1 LIQUID HAVING OXYGEN ABSORBING ABILITY, METHOD FOR PRODUCING SAME, AND COMPLEX SOLUTION CONTAINING SAME Sharp Kabushiki Kaisha (JP) 2018-12-05 EP disclosed
US-20080214386-A1 Stability; easily separated from solution; surface treatment of catalyst with Group seven compound; reacting epoxide with carbon dioxide NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2008-09-04 US disclosed
US-4328170-A Process for preparing an α-cyanoacrylate MATSUMOTO SEIYAKU KOGYO KABUSHIKI KAISHA (JP) 1982-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10814269-B2 Liquid having oxygen absorbing ability, method for producing same, and complex solution containing same MB, OTC, OAT FDPS 3835/4885LMNA 1071/4885DNM1 3089/4885
US-20190291046-A1 OXYGEN SEPARATION MEMBRANE NCLN, OXA1L, MB FDPS 4804/4885LMNA 303/4885DNM1 2214/4885
US-20220127293-A1 LIQUID METAL COMPLEX HAVING OXYGEN-ABSORBING ABILITY OTC, CA9, SLC39A14 FDPS 3624/4885LMNA 1439/4885DNM1 4332/4885
US-20190001260-A1 LIQUID HAVING OXYGEN ABSORBING ABILITY, METHOD FOR PRODUCING SAME, AND COMPLEX SOLUTION CONTAINING SAME MB, OTC, OAT FDPS 3835/4885LMNA 1071/4885DNM1 3089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.